Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1099 of 1,261
  1. US 7129342

    Infectious cDNA clone of GB virus B and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  2. US 7129358

    Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  3. US 7129052

    Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  4. US 7128895

    Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability

    The Regents of the University of California · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  5. US 7128894

    Contrast enhancing solution for use in confocal microscopy

    United States Department of Energy · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  6. DK 1007053

    Behandling af smerte

    AMARIN NEUROSCIENCE LTD [GB] · Granted Oct 30, 2006 · Expires Oct 25, 2026

    granted
  7. US 7125845

    Aza-peptide macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  8. US 7125866

    Therapeutic applications of pro-apoptotic benzodiazepines

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  9. US 7125553

    Methods of inducing immune tolerance using immunotoxins

    The United States of America as represented by the Department of Health and Human Services c/o Centers for Disease Control and Prevention · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  10. US 7125965

    MRI probes of membrane potential

    The Regents of the University of California · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  11. US 7125892

    Aryl aniline β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  12. US 7126008

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  13. US 7125969

    ETS-related gene overexpressed in human breast and epithelial cancers

    The Regents of the University of California · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  14. US 7125857

    Modulators of DNA cytosine-5 methyltransferase and methods for use thereof

    The Regents of the University of California · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  15. US 7125541

    Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

    THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  16. US 7122552

    Inhibitors of JAK and CDK2 protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  17. US 7122214

    Drynaria extractions for treating osteoporosis and their extraction process

    Xiyuan Hospital Affiliated to China Academy of TCM. · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  18. US 7122200

    Vitro engineered, regenerated urinary tract tissue compositions and methods for producing same

    The Board of Regents of the University of Oklahoma · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  19. US 7122558

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall Prodesfarma S.A. · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  20. US 7122714

    Mouse models of human prostate cancer

    The Regents of the University of California · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  21. US 7122681

    Desolvation process for the production of atorvastatin hemi-calcium essentially free of bound organic solvent

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  22. US 7122624

    Parathyroid hormone receptor ligands

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  23. US 7122572

    Calixpyrroles

    The Board of Regents of the University of Texas System · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  24. US 7122542

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.